Ronald Chow

A new open-access publication from our Antiemetics and Emerging Toxicities Study Groups and led by @RonaldCChow and colleagues looks at the prevalence of ADC–induced nausea and vomiting in patients with cancer. Read the full paper here: link.springer.com/article/10.100…

Stanford/Elsevier's Top 2% Scientists List for 2025 is out now! The updated global rankings are live on @topscinet . Explore both career-long and single-year data today. 🌐 Website: topscinet.com

New open-access article in @MASCC_JSCC: Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting—a systematic review and meta-analysis link.springer.com/article/10.100… #SuppOnc

Join us on May 10 for a MASCC webinar: Antibody-Drug Conjugates (ADCs)-Induced Nausea and Vomiting and Long-Delayed CINV: New Unmet Medical Needs Speakers: Prof Florian Scotté, @RonaldCChow, Dr Véronique Dieras and Dr Matti Aapro Learn more or register: us02web.zoom.us/webinar/regist…

We’re pleased to share the newest update to the MASCC/ESMO Antiemetics Guidelines, now available on our website: mascc.org/resources/masc… #SuppOnc

#NewPublication "Prevalence and predictors of long-delayed (> 120 h) chemotherapy-induced nausea and vomiting (CINV)-a systematic review and individual patient data meta-analysis" pubmed.ncbi.nlm.nih.gov/37535218/

“Currently, there are no data regarding the impact of treatment interruptions during radiotherapy for breast cancer,” stated Ronald Chow, MS, FRSPH, and coauthors. Learn more: hmpgloballearningnetwork.com/site/onc/news/… #medtwitter #onctwitter

#NewPublication “Interventions to Improve Outcomes for Caregivers of Patients with Advanced Cancer: a Meta-Analysis” pubmed.ncbi.nlm.nih.gov/37279594/